OncoTargets and Therapy · 2018 · 33 citations · 25 references
MedicineOncologyPharmacologyCancer PharmacologyGene ExpressionMolecular OncologyCancer BiomarkersReactive Oxygen SpeciesAnticancer Natural ProductsCell Cycle-dependent Gene ExpressionLung AdenocarcinomaSoft Agar Colony Formation AssaysWestern Blot Analysis
Purpose: The aim was to investigate resveratrol effects on A549 cells proliferation. Methods: A total of 104 lung adenocarcinoma tissues and nontumor tissues were collected. BEAS-2B cells were cultured in RPMI 1640 medium (group A). A549 cells were treated with RPMI 1640 medium containing different resveratrol concentrations. A549 cells were transfected and grouped as follows: blank group, siRNA-negative control group, siRNA-COX-2 group and resveratrol + siRNA-COX-2 group. qRT-PCR and Western blot were conducted to detect COX-2 expression. MTT assay, soft agar clone assay and flow cytometry were performed to assess proliferation and cell cycle. Results: The relative expression of COX-2 mRNA was significantly increased in lung adenocarcinoma tissues ( P <0.01) and it was closely related with clinical stages. Resveratrol at 60 µmol/L significantly inhibited A549 cells proliferation, S phase cells proportion and COX-2 expression ( P <0.01). COX-2 expression in siRNA-COX-2 group was significantly lower than that in blank group and siRNA-negative control group ( P <0.01). OD 570 values, colony formation rate and S phase cells proportion of resveratrol + siRNA-COX-2 group were much lower than those of other groups ( P <0.01). Conclusion: Resveratrol inhibits A549 cells proliferation by inhibiting COX-2 expression. Keywords: resveratrol, COX-2 expression, A549 cell, proliferation
25
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Thomas Walle, Faye Hsieh, Mark H. DeLegge et al. · Drug Metabolism and Disposition · 2004 · 1.8K citations
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Bharat B. Aggarwal, Anjana Bhardwaj, Rishi S. Aggarwal et al. · PubMed · 2004 · 1.4K citations
Medicine, Oncology, Pharmacology +13
Five‐year lung cancer survival
Tina Wang, Rebecca A. Nelson, Alicia Bogardus et al. · Cancer · 2010 · 173 citations · Full text